Tandem Diabetes Care (NSDQ:TNDM) said today that it has purchased Sugarmate — as mobile app that helps people better manage their diabetes. Financial terms of the deal were not disclosed. Nearly 30,000 people relying on insulin pumps or multiple daily injections presently use the Sugarmate app. Get the full story on our sister site Drug Delivery […]
LeMaitre Vascular acquires Artegraft
LeMaitre Vascular (NSDQ:LMAT) announced that it acquired the business and assets of Artegraft in a deal worth $90 million. Under the terms of the acquisition, LeMaitre will pay $72.5 million in cash at closing, with $65 million for Artegraft, plus $7.5 million in escrow to be released on Dec. 31, 2021. There is an additional $17.5 […]
Lantheus, Progenics complete merger
Lantheus Medical Imaging (NSDQ:LNTH) parent company Lantheus Holdings announced the completion of its merger with Progenics Pharmaceuticals. Progenics, an oncology company developing medicines and artificial intelligence-based technologies for finding, fighting and following cancer, entered into a merger agreement with Lantheus that was first announced on Oct. 2, 2019. Upon the completion of the merger, Progenics stockholders […]
Owens & Minor completes Movianto sale
Owens & Minor (NYSE:OMI) announced that it completed the sale of its Movianto European logistics business to EHDH Holding Group. In January, Owens & Minor announced that it intended to sell the Movianto business, expecting to collect proceeds reaching $133 million to be used to further reduce company debt. The company purchased Movianto in 2012 for […]
Merck acquires Themis to speed COVID-19 vaccine development
Merck (NYSE:MRK) announced today that it completed the acquisition of vaccine and immune-modulation therapy developer Themis for an undisclosed amount. In connection with the acquisition, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, while Merck gained merger control from the Austrian Federal Competition ity, […]
Pandemic forces Proteus into bankruptcy
Proteus Digital Health has filed for Chapter 11 bankruptcy protection, noting that its efforts to raise money or sell the company fell victim to the COVID-19 pandemic. The Redwood City, Calif.-based company missed a $100 million funding target in December. Once valued at $1.5 billion, Proteus previously raised $420 million from investors including Novartis Venture […]
Keystone Heart acquires 510 Kardiac Devices
Keystone Heart today said it has acquired 510 Kardiac Devices for an undisclosed amount. The development-stage 510 Kardiac Devices is currently developing the Lim Transseptal System to meet the demands of left-sided structural heart procedures that require a transeptal approach. The system is important in procedures such as percutaneous treatment of mitral valve disease, percutaneous […]
Sanuwave announces intent to acquire Celularity’s UltraMist
Sanuwave Health (OTC:SNWV) announced that it entered into an exclusive agreement to acquire Celularity’s UltraMist ultrasound healing therapy platform. The non-binding letter of intent includes the acquisition of UltraMist and exclusive partnership rights for Celularity’s wound care biologic products, according to a news release. Celularity develops allogeneic cellular therapies engineered from postpartum human placenta, in cancer, […]
Steeper Group acquires College Park Industries’ Espire Elbow
Steeper Group announced today that it completed the acquisition of College Park Industries’ Espire Elbow prostheses range. Leeds, England-based Steeper Group completed the transaction after a COVID-19-forced delay. After the FTC approved Össur’s acquisition of College Park Industries, the three parties agreed to the delay, but are now able to complete the transaction. Espire Elbow […]
MedTech 100 roundup: Stocks peak to end May
Medtech stocks closed May at their highest point since before the COVID-19 pandemic rocked the markets. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 87.17 points at the end of last week (May 29). That total represents a 2.3% gain from the 85.22-point total at the […]
Haemonetics sells off blood donor software
Haemonetics (NYSE:HAE) announced today that it plans to sell certain blood donor management software assets to the GPI Group. GPI, a provider of IT solutions for healthcare and social services, is purchasing the assets from within Haemonetics’ blood center business unit, according to a news release. Under the agreement, Boston-based Haemonetics and its subsidiary Global Med […]
- 1
- 2
- 3
- …
- 233
- Next Page »
